Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications

Borad, M; Javle, M; Shaib, WL; Mody, K; Bergamo, F; Harris, WP; Damjanov, N; Macarulla, T; Brandi, G; Masi, G; Busset, MDD; Boncompagni, A; Dimova-Dobreva, M; Engelhardt, M; Saulay, M; Halfdanarson, TR; Knox, J; Abou-Alfa, GK; Personeni, N; Mazzaferro, V

ANNALS OF ONCOLOGY, 2022; 33 (7): S567